The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity
Open accessAbstract
Summary Receptor interacting protein kinase 3 (RIP3 or RIPK3) has emerged as a central player in necroptosis and a potential target to control inflammatory disease. Here, three selective small molecule compounds are shown to inhibit RIP3 kinase-dependent necroptosis, although their therapeutic value is undermined by a surprising, concentration-dependent induction of apoptosis. These compounds interact with RIP3 to activate caspase 8 (Casp8) via RHIM-driven recruitment of RIP1 (RIPK1) to assemble a Casp8-FADD-cFLIP complex completely independent of pro-necrotic kinase activities and MLKL. RIP3 kinase-dead D161N mutant induces spontaneous apoptosis independent of compound; whereas, D161G, D143N, and K51A mutants only trigger apoptosis when compound is present. Accordingly, RIP3-K51A mutant mice (Rip3K51A/K51A) are viable and fertile, in stark contrast to the perinatal lethality of Rip3D161N/D161N mice. RIP3 therefore holds both necroptosis and apoptosis in balance through a Ripoptosome-like platform. This work highlights a common mechanism unveiling RHIM-driven apoptosis by therapeutic or genetic perturbation of RIP3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435
Self-citationReceptor Interacting Protein Kinase-3 Determines Cellular Necrotic Response to TNF-α
He, S., Wang, L., Miao, L., Wang, T., Du, F., Zhao, L., & Wang, X. (2009) · Cell · doi:10.1016/j.cell.2009.05.021 · Cited by 2,214
RIP3, an Energy Metabolism Regulator That Switches TNF-Induced Cell Death from Apoptosis to Necrosis
Zhang, D.-W., Shao, J., Lin, J., Zhang, N., Lu, B.-J., Lin, S.-C., Dong, M.-Q., & Han, J. (2009) · Science · doi:10.1126/science.1172308 · Cited by 1,931
Catalytic activity of the caspase-8–FLIPL complex inhibits RIPK3-dependent necrosis
Oberst, A., Dillon, C. P., Weinlich, R., McCormick, L. L., Fitzgerald, P., Pop, C., Hakem, R., Salvesen, G. S., & Green, D. R. (2011) · Nature · doi:10.1038/nature09852 · Cited by 1,278 · cited 17×
“We thank Tak Mak (University of Toronto) for cFLIP / MEF and Fadd / MEF, Astar Winoto (University of California Berkeley) for FADD antibody, Domagoj Vucic (Genentech) for BV6, and Andrew Oberst (University ofWashington) for cFLIP expression plasmids.”
BackgroundInfluentialLi, J., McQuade, T., Siemer, A. B., Napetschnig, J., Moriwaki, K., Hsiao, Y.-S., Damko, E., Moquin, D., Walz, T., McDermott, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.019 · Cited by 1,222
Self-citationRIP3 mediates the embryonic lethality of caspase-8-deficient mice
Kaiser, W. J., Upton, J. W., Long, A. B., Livingston-Rosanoff, D., Daley-Bauer, L. P., Hakem, R., Caspary, T., & Mocarski, E. S. (2011) · Nature · doi:10.1038/nature09857 · Cited by 1,057
Self-citationToll-like Receptor 3-mediated Necrosis via TRIF, RIP3, and MLKL
Kaiser, W. J., Sridharan, H., Huang, C., Mandal, P., Upton, J. W., Gough, P. J., Sehon, C. A., Marquis, R. W., Bertin, J., & Mocarski, E. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.462341 · Cited by 959
Self-citationUpton, J. W., Kaiser, W. J., & Mocarski, E. S. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.01.016 · Cited by 758
Self-citationRIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
Dillon, C. P., Weinlich, R., Rodriguez, D. A., Cripps, J. G., Quarato, G., Gurung, P., Verbist, K. C., Brewer, T. L., Llambi, F., Gong, Y.-N., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.018 · Cited by 562
Research works printed but not linked: 28
- Berger, 2014, Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient mice, J. Immunol., 192, 5476, 10.4049/jimmunol.1400499 · DOI · Paper page
- Carette, 2009, Haploid genetic screens in human cells identify host factors used by pathogens, Science, 326, 1231, 10.1126/science.1178955 · DOI · Paper page
- Degterev, 2008, Expansion and evolution of cell death programmes, Nat. Rev. Mol. Cell Biol., 9, 378, 10.1038/nrm2393 · DOI · Paper page
- Deng, 2012, Discovery of highly potent and selective small molecule ADAMTS-5 inhibitors that inhibit human cartilage degradation via encoded library technology (ELT), J. Med. Chem., 55, 7061, 10.1021/jm300449x · DOI
- Feoktistova, 2011, cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms, Mol. Cell, 43, 449, 10.1016/j.molcel.2011.06.011 · DOI · Paper page
- He, 2011, Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway, Proc. Natl. Acad. Sci. USA, 108, 20054, 10.1073/pnas.1116302108 · DOI · Paper page
- Holderfield, 2013, RAF inhibitors activate the MAPK pathway by relieving inhibitory autophosphorylation, Cancer Cell, 23, 594, 10.1016/j.ccr.2013.03.033 · DOI
- Holler, 2000, Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule, Nat. Immunol., 1, 489, 10.1038/82732 · DOI · Paper page
- Kaczmarek, 2013, Necroptosis: the release of damage-associated molecular patterns and its physiological relevance, Immunity, 38, 209, 10.1016/j.immuni.2013.02.003 · DOI · Paper page
- Kaiser, 2008, Receptor-interacting protein homotypic interaction motif-dependent control of NF-kappa B activation via the DNA-dependent activator of IFN regulatory factors, J. Immunol., 181, 6427, 10.4049/jimmunol.181.9.6427 · DOI · Paper page
- Kaiser, 2013, Viral modulation of programmed necrosis, Curr Opin Virol, 3, 296, 10.1016/j.coviro.2013.05.019 · DOI
- Kasof, 2000, The RIP-like kinase, RIP3, induces apoptosis and NF-kappaB nuclear translocation and localizes to mitochondria, FEBS Lett., 473, 285, 10.1016/S0014-5793(00)01473-3 · DOI
- Micheau, 2002, The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex, J. Biol. Chem., 277, 45162, 10.1074/jbc.M206882200 · DOI · Paper page
- Murphy, 2014, Ars Moriendi; the art of dying well - new insights into the molecular pathways of necroptotic cell death, EMBO Rep., 15, 155, 10.1002/embr.201337970 · DOI
- Newton, 2004, Kinase RIP3 is dispensable for normal NF-kappa Bs, signaling by the B-cell and T-cell receptors, tumor necrosis factor receptor 1, and Toll-like receptors 2 and 4, Mol. Cell. Biol., 24, 1464, 10.1128/MCB.24.4.1464-1469.2004 · DOI · Paper page
- Newton, 2014, Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis, Science, 343, 1357, 10.1126/science.1249361 · DOI · Paper page
- Pazdernik, 1999, Mouse receptor interacting protein 3 does not contain a caspase-recruiting or a death domain but induces apoptosis and activates NF-kappaB, Mol. Cell. Biol., 19, 6500, 10.1128/MCB.19.10.6500 · DOI
- Rebsamen, 2009, DAI/ZBP1 recruits RIP1 and RIP3 through RIP homotypic interaction motifs to activate NF-kappaB, EMBO Rep., 10, 916, 10.1038/embor.2009.109 · DOI · Paper page
- Sun, 1999, RIP3, a novel apoptosis-inducing kinase, J. Biol. Chem., 274, 16871, 10.1074/jbc.274.24.16871 · DOI · Paper page
- Sun, 2012, Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase, Cell, 148, 213, 10.1016/j.cell.2011.11.031 · DOI · Paper page
- Tenev, 2011, The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs, Mol. Cell, 43, 432, 10.1016/j.molcel.2011.06.006 · DOI · Paper page
- Thapa, 2013, Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases, Proc. Natl. Acad. Sci. USA, 110, E3109, 10.1073/pnas.1301218110 · DOI · Paper page
- Uhlmann, 2007, The VP16 activation domain establishes an active mediator lacking CDK8 in vivo, J. Biol. Chem., 282, 2163, 10.1074/jbc.M608451200 · DOI
- Wang, 2008, TNF-alpha induces two distinct caspase-8 activation pathways, Cell, 133, 693, 10.1016/j.cell.2008.03.036 · DOI · Paper page
- Weng, 2014, Caspase-8 and RIP kinases regulate bacteria-induced innate immune responses and cell death, Proc. Natl. Acad. Sci. USA, 111, 7391, 10.1073/pnas.1403477111 · DOI · Paper page
- Xie, 2013, Structural basis of RIP1 inhibition by necrostatins, Structure, 21, 493, 10.1016/j.str.2013.01.016 · DOI · Paper page
- Yu, 1999, Identification of RIP3, a RIP-like kinase that activates apoptosis and NFkappaB, Curr. Biol., 9, 539, 10.1016/S0960-9822(99)80239-5 · DOI
- Zhang, 2011, Functional complementation between FADD and RIP1 in embryos and lymphocytes, Nature, 471, 373, 10.1038/nature09878 · DOI · Paper page
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Self-citationNecroptosis and its role in inflammation
Pasparakis, M., & Vandenabeele, P. (2015) · Nature · doi:10.1038/nature14191 · Cited by 2,148
Necroptosis in development, inflammation and disease
Weinlich, R., Oberst, A., Beere, H. M., & Green, D. R. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.149 · Cited by 1,016
Kuriakose, T., Man, S. M., Subbarao Malireddi, R. K., Karki, R., Kesavardhana, S., Place, D. E., Neale, G., Vogel, P., & Kanneganti, T.-D. (2016) · Science Immunology · doi:10.1126/sciimmunol.aag2045 · Cited by 818
Regulated necrosis: disease relevance and therapeutic opportunities
Conrad, M., Angeli, J. P. F., Vandenabeele, P., & Stockwell, B. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.6 · Cited by 630
Metadata
- Authors
- Mandal, P., Berger, S. B., Pillay, S., Moriwaki, K., Huang, C., Guo, H., Lich, J. D., Finger, J., Kasparcova, V., Votta, B., Ouellette, M., King, B. W., Wisnoski, D., Lakdawala, A. S., DeMartino, M. P., Casillas, L. N., Haile, P. A., Sehon, C. A., Marquis, R. W., Upton, J., Daley-Bauer, L. P., Roback, L., Ramia, N., Dovey, C. M., Carette, J. E., Chan, F. K.-M., Bertin, J., Gough, P. J., Mocarski, E. S., & Kaiser, W. J.
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 2014-11
- Volume
- 56
- Issue
- 4
- Pages
- 481-495
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2169820248
- Cited by
- 618
- References
- 13
- FWCI
- 17.16
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 384 d)
- Funders
- National Institutes of Health (DP1 OD012198, GM112547, R01 AI020211, R01 AI083497, S10 1 S10 RR025679 01)
- GlaxoSmithKline
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity. https://app.cochat.ai/papers/10.1016/j.molcel.2014.10.021
- The paper
- Mandal, P., Berger, S. B., Pillay, S., Moriwaki, K., Huang, C., Guo, H., Lich, J. D., Finger, J., Kasparcova, V., Votta, B., Ouellette, M., King, B. W., Wisnoski, D., Lakdawala, A. S., DeMartino, M. P., Casillas, L. N., Haile, P. A., Sehon, C. A., Marquis, R. W., . . . Kaiser, W. J. (2014). RIP3 Induces Apoptosis Independent of Pronecrotic Kinase Activity. Molecular Cell. https://doi.org/10.1016/j.molcel.2014.10.021
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.